1 year return (CAGR)
45.93%
Corcept Therapeutics Incorporated Exchange (NASDAQ, USD)
CORT
117.50
+3.75 (+3.29%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
51.98%
5 year return (CAGR)
41.77%
10 year return (CAGR)
35.22%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
12.70B
Price/Sales
15.29
Ent value
12.77B
Price/Book
18.00
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
231.39
PEG
-
Forward P/E
26.69
EPS growth
-0.55%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 113.96 |
| Daily high | 119.00 |
| Daily low | 113.09 |
| Daily Volume | 747K |
| All-time high | 123.57 |
| 1y analyst estimate | 141.00 |
| Beta | 0.46 |
| EPS (TTM) | 0.46 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 18 Feb 2026 |
Downside potential
Loading...
Downside potential data
| CORT | S&P500 | |
| Current price drop from All-time high | -4.91% | -0.58% |
| Highest price drop | -94.17% | -56.47% |
| Date of highest drop | 13 Oct 2006 | 9 Mar 2009 |
| Avg drop from high | -52.58% | -10.68% |
| Avg time to new high | 58 days | 12 days |
| Max time to new high | 3297 days | 1805 days |
News
